Sweeteners · Gut & Microbiome
acesulfame-K alters gut microbiome
Part of: • acesulfame-K
🧭 Read this score with how it was built in mindLab and animal results no longer outvote a human study that found nothing
Four animal and cell studies support it; the one human study, in 1,436 children and adolescents, found at most a very weak association.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Acesulfame-K's effect on the human gut microbiome is weakly supported — some reviews and animal work suggest it can shift microbiota, but the human clinical trials that changed microbiota implicated saccharin and sucralose, not ace-K. So, like aspartame, the microbiome concern for ace-K specifically is largely mechanistic/animal, not demonstrated in people.
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Feng J, Peng J, Hsiao YC, Liu CW, Yang Y, Zhao H, Teitelbaum T, Wang X, Lu K 2024 · Metabolites | animal | supports | low | NAS-microbiome review: ace-K effects sporadic, human data limited. |
| De Paepe E, Callemeyn E, De Windt K, Wijnant K, Plekhova V, Pomian B, Vangeenderhuysen P, De Henauw S, Michels N, Viljakainen H, Leppänen MH, Lakka TA, Van De Maele K, Baeck N, De Bruyne R, Lefere S, Geerts A, Vynck M, Vanhaecke L 2025 · EBioMedicine | observational | tested-null | low | In salivary metabolomics of 1436 European children/adolescents, Ace-K (detected for the first time in this biofluid) correlated weakly with excess weight, stress, diet, and Bacillota phylum abundance (|rho|<0.2). |
| Khattab R 2026 · Curr Nutr Rep | observational | supports | low | Mechanistic review: ace-K among sweeteners that can modulate microbiota (largely preclinical). |
| Kidangathazhe A, Amponsah T, Maji A, Adams S, Chettoor M, Wang X, Scaria J 2025 · Frontiers in Microbiology | in-vitro | supports | low | Ex-vivo minibioreactor arrays inoculated with faecal microbiota from 3 healthy donors (4 replicates), sweetener days 7-21, withdrawal to day 35. Acesulfame K (290.6 mg/L) gave the largest rise in Observed/Chao1/ACE diversity, the strongest Bacillaceae enrichment, and a network that lost modularity and split into isolated islands that persisted after withdrawal: 'acesulfame K has a more lasting impact on the network properties and interactions.' Descriptive analysis, no test statistics; in-vitro, not in-vivo human microbiota. |
| Al-Ishaq RK, Kubatka P, Büsselberg D 2023 · Nutrients | observational | supports | low | Sweeteners-microbiome review: ace-K evidence sparse/inconclusive. |
| Jin X, Xu J, Cao Y, Dai Z, Wang R, Ge X, Cai R, Hu Z, Sun X, Chen J, Zhang L 2026 · Infection and drug resistance | in-vitro | mixed | low | Five sweeteners including Ace-K tested on E. coli/B. subtilis monocultures at CAC-permitted doses; Ace-K (like others except saccharin) did not significantly affect bacterial growth but was associated with reduced antibiotic susceptibility |
| Iizuka K 2022 · Nutrients | observational | mixed | low | Review: artificial sweeteners incl. ace-K may alter microbiota, evidence mixed. |
| Bellanco A, Yépez-Notario C, Lozano M, Martínez-Cuesta MC, Requena T 2026 · Journal of agricultural and food chemistry | in-vitro | supports | moderate | Dynamic gut simulator (children's fecal inoculum) showed Ace-K dose-dependent shifts in Anaerostipes, Coprococcus, Subdoligranulum, Blautia, Sutterella, Alistipes, B. thetaiotaomicron, plus dose-dependent decrease in Caco-2 epithelial barri |
| Blasche S, Periwal V, Beristain Covarrubias N, Lindell A, Roux I, Kamrad S, Mozzachiodi S, Bradley R, Ozgur H, Ramachandran B, Benes V, Patil KR 2026 · Molecular Systems Biology | in-vitro | supports | moderate | Screening of 25 gut bacterial strains against 39 sweeteners (including Ace-K) individually and in combination with co-consumed xenobiotics found three-quarters of tested sweeteners individually impacted growth of at least one bacterial stra |
| Gauthier E, Milagro FI, Navas-Carretero S 2024 · Nutrition | observational | contradicts | moderate | Human clinical-trial review: only saccharin and sucralose changed microbiota — not ace-K. |
| Del Pozo S, Gómez-Martínez S, Díaz LE, Nova E, Urrialde R, Marcos A 2022 · Nutrients | observational | tested-null | low | Review focused on sucralose/saccharin: ace-K evidence sparse. |
| Marongiu L, Brzozowska E, Hetjens S, Hoelzle LE, Venturelli S 2025 · Frontiers in nutrition | observational | mixed | low | Narrative review naming acesulfame potassium among seven NNS assessed for effects on human intestinal microbiota; concludes NNS intake is 'linked' to dysbiosis in animals and humans via altered bacterial biochemistry and quorum sensing, wit |
| Conz A, Salmona M, Diomede L 2023 · Nutrients | animal | mixed | low | NNS–microbiota review: ace-K among sweeteners reported to affect microbiota (largely preclinical). |
| Chowdhury CR, Havlik J 2026 · Food chemistry | observational | mixed | moderate | Ace-K-focused review: human studies generally confirm safety within ADI, but preclinical (in vitro/in vivo) models report altered gut microbiota composition, lipid metabolism, and inflammatory/gene-expression pathways, mostly at supraphysio |
| Raoul PC, Romano M, Galli FS, Cintoni M, Capristo E, Mora V, Mele MC, Gasbarrini A, Rinninella E 2025 · Nutrients | animal | mixed | moderate | PRISMA-registered systematic review of 37 animal studies (aspartame n=17, sucralose n=16, Ace-K n=5, saccharin n=4) on inflammatory markers; concludes Ace-K and saccharin showed 'variable, dose-dependent effects' versus more consistent elev |
| Ruiz-Ojeda FJ, Plaza-Díaz J, Sáez-Lara MJ, Gil A 2019 · Adv Nutr | observational | mixed | moderate | Review: only saccharin, sucralose and stevia measurably change human gut microbiota — implying ace-K does not. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.